MedPath

Comparison between two drug combinations in spinal anaesthesia in below umbilical surgeries

Not yet recruiting
Conditions
Measurement and Monitoring, (2) ICD-10 Condition: O||Medical and Surgical,
Registration Number
CTRI/2022/11/047374
Lead Sponsor
Government Hospital
Brief Summary

Spinal anesthesia is the most preferred technique for infraumbilical surgeries. Hyperbaric Ropivacaine has been shown to produce reliable and predictable anesthesia for surgery. Fentanyl, a synthetic lipophilic opioid, and Dexmedetomidine, a new highly selective alpha 2 agonist have been used as neuraxial adjuvants in spinal anesthesia to prolong intraoperative and postoperative analgesia. This study is undertaken to investigate and compare the clinical effects of 0.75% hyperbaric ropivacaine with additives such as fentanyl and dexmedetomidine on spinal anesthesia for infraumbilical surgeries.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients belonging to ASA physical status Class I and Class Patients without any severe comorbid diseases.

Exclusion Criteria
  • Patients having any absolute contraindications for spinal anesthesia such as patient not willing, raised intracranial pressure, severe hypovolemia, bleeding diathesis, local infection and cardiac, respiratory, and CNS diseases are excluded from the study Pregnant females.
  • chronic diseases such as diabetes and hypertension Patients with body mass index >30 kg/m2 Patients shorter than 150 cm.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Onset of sensory blockade1min, 2min, 3min, 4min, 5min, 6min, 7min, 8min, 9min, 10min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 270min, 300min, 330min, 360min
Maximum level of sensory blockade attained and the time taken for the same1min, 2min, 3min, 4min, 5min, 6min, 7min, 8min, 9min, 10min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 270min, 300min, 330min, 360min
Time for two-segment sensory regression1min, 2min, 3min, 4min, 5min, 6min, 7min, 8min, 9min, 10min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 270min, 300min, 330min, 360min
Onset and duration of motor blockade1min, 2min, 3min, 4min, 5min, 6min, 7min, 8min, 9min, 10min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 270min, 300min, 330min, 360min
Total duration of analgesia1min, 2min, 3min, 4min, 5min, 6min, 7min, 8min, 9min, 10min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 270min, 300min, 330min, 360min
Secondary Outcome Measures
NameTimeMethod
Hemodynamic changes, Adverse Effects5min, 10min, 15min, 20min, 25min, 30min, 35min, 40min, 45min, 50min, 55min, 60min

Trial Locations

Locations (1)

Government Hospital Gandhi Nagar

🇮🇳

JAMMU, & KASHMIR, India

Government Hospital Gandhi Nagar
🇮🇳JAMMU, & KASHMIR, India
Dr Supriya Shree
Principal investigator
09719153125
shreesupriya25@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.